Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience

por Palčić Marija, Gomerčić, Hana, Matijaca, Ivan, Kruljac, Lucija, Vusić, Vedran, Hostić, Luka, Vrbanić, Mrsić, Fanika, Radovan, Zrilić, Ivana, Ćelap, Petar, Gaćina
Publicado 2023

Corrigendum to: Post-treatment neutrophil to lymphocyte ratio as a prognostic tool in patients treated with tocilizumab for severe COVID-19 pneumonia - a single center experience

por Gomerčić Palčić, Marija, Matijaca, Hana, Kruljac, Ivan, Vusić, Lucija, Hostić, Vedran, Vrbanić, Luka, Mrsić, Fanika, Zrilić, Radovan, Ćelap, Ivana, Gaćina, Petar
Publicado 2023